Full Program

Time Sunday 17 March
17:00 – 19:00 Welcome Reception
Crowne Plaza Courtyard (Level 4)
Time Monday 18 March
08:45 - 09:00 Welcome and Opening
09:00 - 09:45 Keynote Presentation
Detection and characterization of NPS requires NPS (new performing strategies)
Christophe Stove

New Analytical Methods
Moderators: Tim Scott and Michaela Kenneally

Sponsored by Shimadzu
09:45 - 10:00 The development and validation of a routine LC-HRMS method for dopamine manipulation detection
Madysen Elbourne
10:00 - 10:15 Rapid and fully-automated analysis of 69 drugs of abuse and their metabolites in urine
Samantha Joubert
10:15 - 10:30 A method to determine kava lactone compounds in blood specimens
Gemma Araneta
10:30 - 11:00 Morning Tea

New Analytical Methods
Moderators: Matt Hosking and Amanda Thompson

Sponsored by Shimadzu
11:00 - 11:15 Comprehensive Toxicological Analyses in Blood using LC-QTOF/MS and LC-Orbitrap/MS
Baohui Fu
11:15 - 11:30 Fully Automated Online Extraction and Analysis of Opiates in Urine by MPS-GC-MS
Chee Ann Ng
11:30 - 11:45 Method development, optimisation, and validation by LC-MS/MS method for 76 new psychoactive substances in wastewater
Dhayaalini Nadarajan
11:45 - 12:00 Validation of cocaine and opioids in urine using SPE and LC-QQQ
Eric Teoh
12:00 - 12:15 Quantification of Menthol in Equine Urine using Gas Chromatography-tandem Mass Spectrometry
Rinika Barua
12:15 - 12:30 Future Proofing a Validated Oral Fluid Method
Karen Thai
12:30 - 13:30 Lunch

Emerging Drug Network of Australia
Moderators: Jennifer Schumann and Jessamine Soderstrom

Sponsored byEDNA
13:30 - 13:45 Introduction to EDNA
Jessamine Soderstrom
13:45 - 14:00 WISE to EDNA – What drugs and trends were observed over the last 8 years?
Paul Sakrajda
14:00 - 14:15 Novel harm minimisation measures at music festivals in Australia: pilot implementation of the Emerging Drugs Network of Australia – Victoria toxicosurveillance methodology
Rebekka Syrjanen
14:15 - 14:30 Prevalence of pregabalin in EDNA and drugs in driving casework in Western Australia (2022-23)
David Brown
14:30 - 14:45 Detections of GHB over two years in Australian Emergency Departments
Emma Partridge
14:45 - 15:00 Nitazenes in Australia: Emergency Department (ED) presentations with analytically confirmed ‘nitazenes’ from the Emerging Drugs Network of Australia (EDNA)
Courtney Weber
15:00 - 15:30 Afternoon tea

General Toxicology
Moderators: Dimitri Gerostamoulos and Chris Kostakis

Sponsored byNova Chem
15:30 - 15:45 The clinical utility of metabolomics: from bench to bedside
Jinni Yan
15:45 - 16:00 Metabolic biotransformation of fifth-generation synthetic cannabinoids
Eathan Walker
16:00 - 16:15 A chemical investigation of Acacia plant material for mental resilience and well-being
Pragna Gaur
16:15 - 16:30 Implementation and early results of a unique drink spiking initiative in Western Australia (WA)
Banafsheh Behrouzi
16:30 - 16:45 Drugs of abuse detected in oral fluid samples of Victorian drivers
Linda Glowacki
16:45 - 17:00 Oral fluid analysis: What is present on NSW roads and an investigation into negative results
Angela Turville
Time Tuesday 19 March
7.30am – 8.30am
Update on SCIEX hardware, including the Advancement of Acoustic Ejection Mass Spectrometry for high-throughput sample analysis

  • Learn about Acoustic Ejection Mass Spectrometry and see details of next generation systems
  • PLUS get an update on the action items and suggestions Brad took away from the last FACTA meeting in April 2022
  • PLUS get a free breakfast and hot beverage!
09:00 - 09:45 Keynote Presentation
Welcome to the post-heroin, post-fentanyl era?
Christophe Stove
New Psychoactive Substances
Moderators: Jennifer Schumann and Michaela Kenneally
09:45 - 10:00 Detection of Nitazene (2-Benzylbenzimidazole) novel synthetic opioids in coronial forensic casework in Victoria, Australia
Lachlan Scully
10:00 - 10:15 Nitazene detections in Queensland Illicit Drugs casework submissions
Vicky Cusack
10:15 - 10:30 Improving wastewater-based epidemiology for monitoring of new psychoactive substances by combining a high-throughput in vitro metabolism assay and LC−HRMS metabolite identification
Richard Bade
10:30 - 11:00 Morning Tea
New Psychoactive Substances
Moderators: Naren Gunja and Thomas Keller
11:00 - 11:45 Keynote Presentation
Methamphetamine: Behavioural and clinical manifestation
Rebecca McKetin
11:45 - 12:00 NSW approach to drug-related harm and illicit substance detections at music festivals
Thanjira Jiranantakan
12:00 - 12:15 The emergence of N,N-dimethylpentylone in South Australia
Michaela Kenneally
12:15 - 12:30 Identification of 2’-fluoro-2-oxo-PCE in emergency cases in Queensland
Melissa Trujillo Uruena
12:30 - 13:30 Lunch
New Psychoactive Substances
Moderators: Shanlin Fu and Amanda Thompson
13:30 - 14:15 Keynote Presentation
MDMA-assisted therapy: Current and emerging applications
Paul Liknaitzky
14:15 - 14:30 Toxicoepidemiology of forensic detections in Western Sydney
Naren Gunja
14:30 - 14:45 New psychoactive substances in Queensland drug analysis: Trends and shared challenges
Karen Blakey
14:45 - 15:00 Immediate Life-threatening events following smoking of substances containing Cumyl-Pegaclone
Petra van Nieuwenhuijzen
15:00 - 15:30 Afternoon tea
Moderators: Tim Scott and Matt Hosking
15:30 - 15:45 Reportable deaths after drug use and oleoresin capsicum (OC) exposure in Victoria
William McMaster
15:45 - 16:00 Solid Phase Extraction of Novel Synthetic 2-Benzylbenzimidazole Opioids Compounds, “Nitazenes”
Emily Eng
16:00 - 16:15 Crash risk of drugs in injured drivers in Victoria, Australia – an update
Olaf Drummer
16:15 - 17:00 Panel Session - Amphetamines in the Community
Paul Liknaitzky, Rebecca McKetin, Olaf Drummer, Tim Scott (Chair)
19:00 – 22:30 Conference Dinner
Hobart Function and Conference Centre
Time Wednesday 20 March
09:00 –9:45 Keynote Presentation
Dried blood microsampling & alcohol biomarkers: a perfect marriage?
Christophe Stove
Workplace Testing
Moderators: Linda Glowacki and Matt Hosking
09:45 – 10:00 Potential for drug-use masking in the workplace
John Edwards
10:00 - 10:15 Can cannabis be accurately quantified in urine using a rapid multi-analyte drugs of abuse method?
Samantha Joubert
10:15 - 10:30 Update on the revision of AS 4308-2008 Procedures for specimen collection and the detection and quantification of drugs in urine
Michael Robertson
10:30 - 11:00 Morning Tea
Post-Mortem Toxicology
Moderators: Olaf Drummer and David Brown
11:00 - 11:15 Psychedelic spores: Deaths involving psilocin and bufotenine
Hannah Double
11:15 - 11:30 Xylazine in a suicide – a case study highlighting the importance of full scan mass spectral data acquisition and commercial mass spectral libraries
Danielle Butzbach
11:30 - 11:45 Putrefaction causes reductive transformation of oxazepam and temazepam
Shanlin Fu
11:45 - 12:00 Death from alcohol: use of ethanol-based solutions in the home
Elizabeth Gould-Williams
12:00 - 12:15 Keeping an eye on the big picture - an unusual vitreous result
Chris Kostakis
12:15 - 12:30 Using mass spectrometry approach for toxicological investigation of functional neurological disorder (FND)
Manal Nasser Alhosawi
12:30 - 13:30 Lunch
General Toxicology
Moderators: Michaela Kenneally and Christophe Stove

Sponsored byNova Chem
13:30 - 13:45 An untargeted approach for the hypothesis generation of metabolomic biomarkers from an exogenous steroid administration
Madysen Elbourne
13:45 - 14:00 Novel benzodiazepines and counterfeit alprazolam in NSW
Janette Smith
14:00 - 14:15 Comparison of Presumptive Fentanyl Testing Methods
Archie Lambrinos
14:15 - 14:30 Methylamphetamine detected in child deaths reported to the Victorian Coroner: A retrospective observational study
Dylan Mantinieks
14:30 - 14:45 Does variation in street-level heroin contribute to overdose cases? Insights from a Supervised Injecting Facility in Melbourne, Australia.
Nathan Stam
14:45 - 15:15 Afternoon tea
15:15 - 16:15 FACTA Business
Committee reports, AGM, Elections, Awards